Ascendis Publishes Preclinical Findings Supporting Use of TransCon PTH in Human Patients
TransCon PTH normalizes blood levels of calcium and phosphate, and reduces the amount of calcium released in the urine in different animal models, a study shows. These preclinical results support the therapy’s use by people with hypoparathyroidism, the researchers say. The results, “Design and Preclinical Development of…